Cao B - Search Results

1

[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].

Xu B, Tian F, Yu J, Song Y, Shi J, Zhang B, Zhang Y, Yuan Z, Wu Q, Zhang Q, Nan K, Sun Q, Li W, Hu J, Bi J, Meng C, Dai H, Jiang H, Yue S, Cao B, Sun Y, Wang S, Tong Z, Shen P, Wu G, Tang L, Deng Y, Jia L, Shen K, Zhuang W, Xie X, Wu Y, Chen L. Xu B, et al. Among authors: cao b. Zhonghua Zhong Liu Za Zhi. 2016 Jan;38(1):23-7. doi: 10.3760/cma.j.issn.0253-3766.2016.01.005. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 26796802 Clinical Trial. Chinese.

2

Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.

Yu J, Xiao J, Yang Y, Cao B. Yu J, et al. Among authors: cao b. Medicine (Baltimore). 2015 Jul;94(27):e1072. doi: 10.1097/MD.0000000000001072. Medicine (Baltimore). 2015. PMID: 26166081 Free PMC article. Review.

3

The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis.

Yan H, Li H, Li Q, Zhao P, Wang W, Cao B. Yan H, et al. Among authors: cao b. PLoS One. 2015 Aug 18;10(8):e0135829. doi: 10.1371/journal.pone.0135829. eCollection 2015. PLoS One. 2015. PMID: 26285137 Free PMC article. Review.

4

Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients.

Yan H, Li Q, Wang W, Zhen H, Cao B. Yan H, et al. Among authors: cao b. Sci Rep. 2015 Oct 20;5:15355. doi: 10.1038/srep15355. Sci Rep. 2015. PMID: 26481697 Free PMC article.

5

Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.

Li Q, Yan H, Zhao P, Yang Y, Cao B. Li Q, et al. Among authors: cao b. Sci Rep. 2015 Oct 27;5:15746. doi: 10.1038/srep15746. Sci Rep. 2015. PMID: 26503902 Free PMC article.

6

Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patients.

Han Y, Wang H, Xu W, Cao B, Han L, Jia L, Xu Y, Zhang Q, Wang X, Zhang G, Yu M, Yang G. Han Y, et al. Among authors: cao b. Complement Ther Med. 2016 Feb;24:81-9. doi: 10.1016/j.ctim.2015.12.008. Epub 2015 Dec 28. Complement Ther Med. 2016. PMID: 26860807 Free article.

7

Meta-analysis comparing maintenance strategies with continuous therapy and complete chemotherapy-free interval strategies in the treatment of metastatic colorectal cancer.

Zhao L, Wang J, Li H, Che J, Cao B. Zhao L, et al. Among authors: cao b. Oncotarget. 2016 May 31;7(22):33418-28. doi: 10.18632/oncotarget.8644. Oncotarget. 2016. PMID: 27072579 Free PMC article. Review.

8

Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study.

Qin S, Li J, Bai Y, Shu Y, Li W, Yin X, Cheng Y, Sun G, Deng Y, Zhong H, Li Y, Qian X, Zhang L, Zhang J, Chen K, Kang W; HLX04-mCRC03 Investigators. Qin S, et al. BioDrugs. 2021 Jul;35(4):445-458. doi: 10.1007/s40259-021-00484-9. Epub 2021 May 20. BioDrugs. 2021. PMID: 34014555 Free PMC article. Clinical Trial.

9

Safety and efficacy of spleen aminopeptide oral lyophilized powder for improving quality of life and immune response in patients with advanced breast cancer: a multicenter, randomized, double-blind, placebo-controlled clinical trial.

Wang J, Ma X, Shang K, Wu S, Ma Y, Ma Z, Cao B. Wang J, et al. Among authors: cao b. Anticancer Drugs. 2021 Nov 1;32(10):1067-1075. doi: 10.1097/CAD.0000000000001109. Anticancer Drugs. 2021. PMID: 34261911 Free PMC article. Clinical Trial.

10

Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.

Zhao P, Zhen H, Zhao H, Zhao L, Cao B. Zhao P, et al. Among authors: cao b. BMC Cancer. 2022 Mar 26;22(1):328. doi: 10.1186/s12885-022-09444-0. BMC Cancer. 2022. PMID: 35346117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,231 results

Search Page

Filters